Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE)
- Trial number:
- NCT04965259
- Trial phase:
- N/A
- Study type:
- Observational
- Overall status:
- Recruiting
Study start date
Scientific title
Summary
Male and female patients, 50 to 90 years of ago at the time of signing the informed consent form.Patient has serum alpha-fetoprotein (AFP) within normal range of the investigating laboratory in the past 3 months Patient has ultrasound hepatobiliary system (US HBS) that does not show lesion suspicious for HCC or, CT / MRI scan that exclude HCC, in the past 3 months Patient has chronic liver disease other than HCC in the last 5 years Patient is estimated to survive more than 3 years
Patient with any of the following chronic liver disease:
liver cirrhosis of any etiology, identified by elastography (liver stiffness > 13 kPa), US, CT, MRI or liver biopsy, Child-Pugh class A and B (based on the judgement of the Investigator)non-cirrhotic chronic viral hepatitis (B or C) or both non-alcoholic fatty liver disease (NAFLD) non-alcoholic steatohepatitis (NASH) Patient is able to comply with scheduled visits, assessments and other study procedures Patient is willing to provide informed consent before enrolment in the study